Entity type | Description | Example entity* |
---|---|---|
SLR 1 | ||
 Arm description | Treatment arm description phrase | ‘dexamethasone’ |
 Arm dosage | Amount or frequency of a treatment | ‘We treated patients with drug X at 1.3 mg/m2’ |
 PFS metric | Metric used to describe PFS | ‘median progression-free survival’ |
 PFS result | Numeric measurement associated with a PFS metric | ‘10 months’ |
 Study type | Type of study design | ‘randomized controlled trial’ |
 Title | Title of the publication | ‘A study to investigate multiple myeloma’ |
 Authors | Authors of the publication | ‘M Smith’ |
SLR 2 | ||
 Age metric | Metric used to measure the age of patient populations | ‘mean (SD) age’ |
 Age number | Numeric measurement associated with an age metric | ‘60 years’ |
 Arm description | Treatment arm description phrase | ‘dexamethasone’ |
 Arm dosage | Amount or frequency of a treatment | ‘We treated patients with drug X at 1.3 mg/m2’ |
 eGFR metric | Metric used to describe eGFR | ‘mean eGFR’ |
 eGFR number | Numeric measurement associated with an eGFR metric | ‘20 mL/min/1.73 m2’ |
 eGFR subgroup | Population subgroup | ‘Among patients >60 years old’ |
 eGFR time point | Time period over which the metric was measured | ‘at 4-month follow-up’ |
 Study type | Type of study design | ‘observational study’ |